
CEO | Founder
Brent Chamberlain
Biopharma and quality
MYKITO SCIENCESMykito Sciences exists to unlock the industrial potential of chitosan by replacing constrained animal supply with controlled, non-animal production and material engineering.
The company began with the potential of fungal fermentation to create repeatable material without the beta-glucans, heavy metals and other contaminants that can complicate conventional supply.
Today, Mykito connects source platforms, molecular engineering and application-ready formats to help customers build products—not merely evaluate another raw ingredient.
The goal is simple: manufacture chitosan around the specification, not around what a crustacean shell happens to yield.
Mykito brings together deep experience in biopharma, quality, purification, fermentation, process engineering, venture building and chitosan commercialization.

CEO | Founder
Biopharma and quality

COO | CFO
25-year venture capital background

VP Product & Attribute Sciences
46 years of purification and analytical expertise

VP Business Development
10 years of chitosan experience and 25 years of business development experience

VP Process Sciences & Engineering
51 years of fermentation expertise
HOW WE WORK
Build supply around renewable, non-animal biological inputs.
Control the attributes that determine performance in the final application.
Deliver formats and formulations that move customer programs forward.